TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Antengene Corporation Limited ( (HK:6996) ) has shared an update.
Antengene Corporation Limited has announced its intention to conduct an on-market share repurchase, utilizing a mandate approved by shareholders to buy back up to 10% of its issued shares. This move, subject to market conditions, is aimed at demonstrating confidence in the company’s business outlook and enhancing shareholder value, with the repurchase financed by internal resources.
More about Antengene Corporation Limited
Antengene Corporation Limited is a biopharmaceutical company focused on developing and commercializing innovative oncology medicines. The company operates primarily in the field of cancer treatment, aiming to address unmet medical needs in the Asia-Pacific markets.
YTD Price Performance: 462.50%
Technical Sentiment Signal: Strong Sell
Current Market Cap: €241.8M
For detailed information about 6996 stock, go to TipRanks’ Stock Analysis page.